Hanafusa H - Search Results

1

Common BRCA1 variants and transcriptional activation.

Monteiro AN, August A, Hanafusa H. Monteiro AN, et al. Among authors: hanafusa h. Am J Hum Genet. 1997 Sep;61(3):761-2. doi: 10.1086/515515. Am J Hum Genet. 1997. PMID: 9326340 Free PMC article. No abstract available.

2

Evidence for a transcriptional activation function of BRCA1 C-terminal region.

Monteiro AN, August A, Hanafusa H. Monteiro AN, et al. Among authors: hanafusa h. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13595-9. doi: 10.1073/pnas.93.24.13595. Proc Natl Acad Sci U S A. 1996. PMID: 8942979 Free PMC article.

3

BRCA1 regulates p53-dependent gene expression.

Ouchi T, Monteiro AN, August A, Aaronson SA, Hanafusa H. Ouchi T, et al. Among authors: hanafusa h. Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2302-6. doi: 10.1073/pnas.95.5.2302. Proc Natl Acad Sci U S A. 1998. PMID: 9482880 Free PMC article.

4

CrkII regulates focal adhesion kinase activation by making a complex with Crk-associated substrate, p130Cas.

Iwahara T, Akagi T, Fujitsuka Y, Hanafusa H. Iwahara T, et al. Among authors: hanafusa h. Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17693-8. doi: 10.1073/pnas.0408413102. Epub 2004 Dec 14. Proc Natl Acad Sci U S A. 2004. PMID: 15598735 Free PMC article.

5

CrkII induces serum response factor activation and cellular transformation through its function in Rho activation.

Iwahara T, Akagi T, Shishido T, Hanafusa H. Iwahara T, et al. Among authors: hanafusa h. Oncogene. 2003 Sep 4;22(38):5946-57. doi: 10.1038/sj.onc.1206633. Oncogene. 2003. PMID: 12955073

6

FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts.

Kakumoto K, Sasai K, Sukezane T, Oneyama C, Ishimaru S, Shibutani K, Mizushima H, Mekada E, Hanafusa H, Akagi T. Kakumoto K, et al. Among authors: hanafusa h. Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5490-5. doi: 10.1073/pnas.0601222103. Epub 2006 Mar 28. Proc Natl Acad Sci U S A. 2006. PMID: 16569692 Free PMC article.

7

Loss of c-abl facilitates anchorage-independent growth of p53- and RB- deficient primary mouse embryonic fibroblasts.

Suzuki J, Sukezane T, Akagi T, Georgescu MM, Ohtani M, Inoue H, Jat PS, Goff SP, Hanafusa H, Shishido T. Suzuki J, et al. Among authors: hanafusa h. Oncogene. 2004 Nov 4;23(52):8527-34. doi: 10.1038/sj.onc.1207894. Oncogene. 2004. PMID: 15378021

8

Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation.

Akagi T, Sasai K, Hanafusa H. Akagi T, et al. Among authors: hanafusa h. Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13567-72. doi: 10.1073/pnas.1834876100. Epub 2003 Nov 3. Proc Natl Acad Sci U S A. 2003. PMID: 14597713 Free PMC article.

9

Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.

Georgescu MM, Kirsch KH, Kaloudis P, Yang H, Pavletich NP, Hanafusa H. Georgescu MM, et al. Among authors: hanafusa h. Cancer Res. 2000 Dec 15;60(24):7033-8. Cancer Res. 2000. PMID: 11156408

10

The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.

Georgescu MM, Kirsch KH, Akagi T, Shishido T, Hanafusa H. Georgescu MM, et al. Among authors: hanafusa h. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10182-7. doi: 10.1073/pnas.96.18.10182. Proc Natl Acad Sci U S A. 1999. PMID: 10468583 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results